文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives.肥厚型心肌病——当前挑战与未来展望

J Clin Med. 2023 Sep 21;12(18):6093. doi: 10.3390/jcm12186093.

2

[Pulsed Doppler echocardiographic assessment of diastolic left ventricular hemodynamics in hypertrophic cardiomyopathy: relationship between the mode of left ventricular filling and the distribution of left ventricular hypertrophy].肥厚型心肌病左心室舒张期血流动力学的脉冲多普勒超声心动图评估：左心室充盈模式与左心室肥厚分布的关系

J Cardiogr. 1983 Sep;13(3):523-35.

3

T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.T1 Mapping在肥厚型表型鉴别中的应用：高血压性心脏病和肥厚型心肌病：国际T1多中心心血管磁共振研究结果

Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.115.003285.

4

Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.高血压性心脏病与肥厚型心肌病：舒张末期室壁厚度≥15mm时的多参数心血管磁共振鉴别指标

Eur Radiol. 2017 Mar;27(3):1125-1135. doi: 10.1007/s00330-016-4468-2. Epub 2016 Jul 1.

5

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.肥厚型心肌病中心脏磁共振成像评估左心室结构和舒张功能

Indian Heart J. 2018 Jan-Feb;70(1):75-81. doi: 10.1016/j.ihj.2016.12.021. Epub 2017 Jan 6.

6

Revelation of an obstructive hypertrophic cardiomyopathy in an elderly patient.老年患者梗阻性肥厚型心肌病的揭示。

Int J Cardiol. 2010 Nov 19;145(2):e41-e43. doi: 10.1016/j.ijcard.2008.12.136. Epub 2009 Jan 31.

7

Strain analysis during exercise in patients with left ventricular hypertrophy: impact of etiology.在左心室肥厚患者运动期间的应变分析：病因的影响。

J Am Soc Echocardiogr. 2013 Oct;26(10):1163-1169. doi: 10.1016/j.echo.2013.06.002. Epub 2013 Jul 13.

8

Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.主动脉瓣下间隔心肌切除术的外科病理学：组织学跳过临床诊断。

Cardiovasc Pathol. 2018 Mar-Apr;33:32-38. doi: 10.1016/j.carpath.2017.12.002. Epub 2018 Jan 3.

9

Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.左心室肥厚患者的心肌甘油三酯含量：高血压性心脏病与肥厚型心肌病的比较。

Heart Vessels. 2017 Feb;32(2):166-174. doi: 10.1007/s00380-016-0844-8. Epub 2016 May 3.

10

Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.心脏磁共振成像评估左心室肥厚在区分高血压性心脏病与致心肌病变基因突变的肥厚型心肌病。

Eur Radiol. 2011 Jul;21(7):1383-9. doi: 10.1007/s00330-011-2065-y. Epub 2011 Jan 28.

引用本文的文献

1

Cardiac myosin inhibitors: Efficacy, safety and future directions of aficamten in hypertrophic obstructive cardiomyopathy.心肌肌球蛋白抑制剂：阿非卡坦治疗肥厚性梗阻性心肌病的疗效、安全性及未来方向

Egypt Heart J. 2025 Jun 13;77(1):61. doi: 10.1186/s43044-025-00652-0.

2

A Systematic Review and Meta-analysis of Efficacy and Safety of Mavacamten for the Treatment of Hypertrophic Cardiomyopathy.马伐卡坦治疗肥厚型心肌病疗效与安全性的系统评价和荟萃分析

Rev Cardiovasc Med. 2024 Oct 23;25(10):375. doi: 10.31083/j.rcm2510375. eCollection 2024 Oct.

3

Myosin-Catalyzed ATP Hydrolysis in the Presence of Disease-Causing Mutations: Mavacamten as a Way to Repair Mechanism.肌球蛋白催化致病突变体存在下的 ATP 水解：mavacamten 作为修复机制的一种方法。

J Phys Chem B. 2024 May 16;128(19):4716-4727. doi: 10.1021/acs.jpcb.4c01601. Epub 2024 May 6.

本文引用的文献

1

Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives.肥厚型心肌病的诊断与治疗再探讨：当前实践与新观点

J Clin Med. 2023 Sep 1;12(17):5710. doi: 10.3390/jcm12175710.

2

2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。

Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.

3

Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine.儿童和成人肥厚型心脏病患者的靶向治疗：从分子病理生理学到个体化医学。

Circ Heart Fail. 2023 Aug;16(8):e010687. doi: 10.1161/CIRCHEARTFAILURE.123.010687. Epub 2023 Jul 21.

4

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者的心律失常风险分层

J Clin Med. 2023 May 10;12(10):3397. doi: 10.3390/jcm12103397.

5

Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines.多发性黑子性先天性色素沉着综合征肥厚型心肌病的自然病史。

Circ Genom Precis Med. 2023 Aug;16(4):350-358. doi: 10.1161/CIRCGEN.122.003861. Epub 2023 May 18.

6

Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal Hypertrophy.接受经冠状动脉室间隔肥厚消融术的肥厚性梗阻性心肌病成年患者的性别差异

J Clin Med. 2023 Apr 21;12(8):3024. doi: 10.3390/jcm12083024.

7

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective.肥厚性梗阻性心肌病患者的酒精间隔消融术：当代观点

J Clin Med. 2023 Apr 11;12(8):2810. doi: 10.3390/jcm12082810.

8

Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice.儿科亲属肥厚型心肌病的临床与基因筛查：临床实践中的范式转变

J Clin Med. 2023 Apr 9;12(8):2788. doi: 10.3390/jcm12082788.

9

Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy.梗阻性肥厚型心肌病患者使用丙吡胺的真实世界应用及反应预测因素

J Clin Med. 2023 Apr 6;12(7):2725. doi: 10.3390/jcm12072725.

10

Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions.肥厚型心肌病的基因检测与咨询：常见问题解答

J Clin Med. 2023 Mar 24;12(7):2489. doi: 10.3390/jcm12072489.

肥厚型心肌病——当前挑战与未来展望

Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives.

作者信息

Monda Emanuele, Limongelli Giuseppe, Pelliccia Francesco

机构信息

Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.

Department of Cardiovascular Sciences, Sapienza University, 00185 Rome, Italy.

出版信息

J Clin Med. 2023 Sep 21;12(18):6093. doi: 10.3390/jcm12186093.

DOI:10.3390/jcm12186093

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10531662/

Abstract

Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterized by left ventricular (LV) hypertrophy, which cannot be entirely attributed to loading conditions such as valve or congenital heart disease or hypertension [...].

摘要

肥厚型心肌病（HCM）是一种以左心室（LV）肥厚为特征的心肌疾病，其不能完全归因于诸如瓣膜病、先天性心脏病或高血压等负荷情况[……]